Clik here to view.
住友质子治疗系统获得FDA 510(k)批准
Smart Multimedia Gallery Gantry Treatment System (Photo: Business Wire) View and Share Photo Download Small 东京 (美国商业资讯)–住友重机械工业株式会社(Sumitomo Heavy Industries, Ltd.,...
View ArticleClik here to view.
Fujifilm Announces New Platform in Digital Mammography Portfolio – Amulet...
STAMFORD, Conn. Today at the 99th annual meeting of the Radiological Society of North America (RSNA), FUJIFILM Corporation, Tokyo, Japan, introduced its latest and most innovative digital...
View ArticleClik here to view.
Alvotech Invests $250 Million in Biopharmaceuticals
Smart Multimedia Gallery Alvotech’s development and manufacturing center in Reykjavik, Iceland. (Photo: Business Wire) View and Share Photo Download Small REYKJAVIK, Iceland Alvotech, a powerful new...
View ArticleClik here to view.
PhotoMedex Terminates Distribution Agreement in Japan
MONTGOMERYVILLE, Pa. PhotoMedex, Inc. (NASDAQ and TASE: PHMD) announced today the termination of the exclusive distribution agreement between its wholly-owned subsidiary Radiancy, Inc. and Ya-Man...
View ArticleClik here to view.
Updated Data with Oral Proteasome Inhibitor MLN9708 Reported in Newly...
NEW ORLEANS & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) today announced final Phase 1 and preliminary Phase 2 results of a study combining oral investigational MLN9708...
View ArticleClik here to view.
KineMed President and Scientific Founder Marc Hellerstein to Present the Role...
EMERYVILLE, Calif. KineMed, Inc. (www.kinemed.com) announced today that Marc Hellerstein, M.D., Ph.D., President, CSO, and Scientific Founder of KineMed, will present at the 7th Cachexia Conference...
View ArticleClik here to view.
Nobel Laureate Zinkernagel Delivers Keynote Speech at NCKU
TAINAN, Taiwan National Cheng Kung University (NCKU) hosted the 2013 International Symposium on Infectious Disease and Signal Transduction together with the 2013 Taiwan-Japan Joint Symposium on Cell...
View ArticleClik here to view.
Innate Immunotherapeutics Completes $10M IPO
SYDNEY Innate Immunotherapeutics is pleased to announce it has successfully raised A$10 million through its Initial Public Offer (IPO) and will immediately commence planning its clinical trial for...
View ArticleClik here to view.
BeiGene Enrolls First Patient in Phase 1 Study of BGB-283
BEIJING BeiGene (Beijing), Co., Ltd., today announced dose administration for the first patient in a Phase 1 study of BGB-283 in patients with B-RAF or K-RAS mutations. BGB-283 is an...
View ArticleClik here to view.
Blaze Bioscience Announces Initiation of First-in-Human Phase 1 Clinical...
SEATTLE & MELBOURNE, Australia Blaze Bioscience, Inc. and its subsidiary, Blaze Bioscience Australia Pty Ltd, today announced the initiation of the first Phase 1 clinical study of the first...
View ArticleClik here to view.
World’s First MEVION S250 Proton Therapy Treatment Delivered at Barnes-Jewish...
Smart Multimedia Gallery View of the MEVION S250 Proton Therapy System treatment room at the Siteman Cancer Center at Barnes-Jewish Hospital in St. Louis, MO. (Photo: Business Wire) View and Share...
View ArticleClik here to view.
世界初のMEVION S250による陽子線治療をバーンズ・ジューイッシュ病院で実施
Smart Multimedia Gallery View of the MEVION S250 Proton Therapy System treatment room at the Siteman Cancer Center at Barnes-Jewish Hospital in St. Louis, MO. (Photo: Business Wire) View and Share...
View ArticleClik here to view.
Navidea Biopharmaceuticals Expands Lymphoseek® Global Commercialization Efforts
DUBLIN, Ohio Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today it has entered into a distribution...
View ArticleClik here to view.
エリテックがリードプロダクトを固形腫瘍向けに展開し、すい臓がんの第II相臨床研究を開始
仏リヨン （ビジネスワイヤ） — Regulatory News: 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的治療薬の開発に当たっているフランスのバイオ製薬企業エリテック・ファーマ（Euronext Paris: FR0011471135 –...
View ArticleClik here to view.
Semler Research Center US Appoints Dr Nuggehally Srinivas as the President of...
AGOURA HILLS, Calif. Semler Research Center US (SRC US) has announced its formation of a new business unit within Arnold A Semler Inc, which also owns SRC India, and the appointment of Dr Nuggehally...
View ArticleClik here to view.
エリテックがAMLにおける欧州での第 IIb相試験につき、フィンランドとスペインで臨床試験実施許可を取得と発表
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的治療薬の開発に当たっているフランスのバイオ製薬企業エリテック・ファーマ（Paris:ERYP）（NYSE Euronext Paris: FR0011471135 – ERYP）は、フィンランドとスペインで急性骨髄性白血病（AML）における第...
View ArticleClik here to view.
Seattle Genetics Announces ADCETRIS® (Brentuximab Vedotin) Approval in Japan...
BOTHELL, Wash. Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that its collaborator, Takeda Pharmaceutical Company Limited (Takeda), has received approval of ADCETRIS (brentuximab vedotin)...
View ArticleClik here to view.
Biocon Collaborates with Advaxis for ‘ADXS-HPV’ A Novel Cancer Immunotherapy
BANGALORE, India & PRINCETON, N.J. Biocon Ltd., (BIOCON.BO), Asia’s premier biotechnology company, and Advaxis, Inc., (NASDAQ: ADXS), a leader in developing the next generation of cancer...
View ArticleClik here to view.
Starpharma Commences Dendrimer-Docetaxel Clinical Trial
MELBOURNE, Australia Starpharma (ASX:SPL)(OTCQX:SPHRY) today announced that it has received the necessary approvals to commence a phase 1 human clinical trial for its dendrimer-enhanced docetaxel...
View ArticleClik here to view.
Covidien Launches Advanced Medical Training and Education Center in India
MUMBAI, India Further developing its capabilities in a key emerging market, Covidien (NYSE:COV) has officially opened its first training and education center in India. The Covidien Center of...
View Article